Salute e Benessere

Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into…

In the future, Cencora will also have access to the future Sapphiros technologies including a fully disposable, low-cost multiplexed molecular diagnostics platform, additional rapid lateral flow tests for diseases beyond COVID-19 and the Satio™ novel blood collection patch coming in early 2024. In the future, Cencora will also have access to the future Sapphiros technologies including a fully disposable, low-cost multiplexed molecular diagnostics platform, additional rapid lateral flow tests...
PR Newswire
22/11/2023

Veeva European Commercial Summit Gathers Life Sciences Industry Leading the Next…

One of largest gatherings of life sciences leaders in Europe, Veeva Commercial Summit will host over 1,300 industry professionals across more than 100 sessions. Astellas, Bayer, and GSK will headline the opening keynote joining Chris Moore, president of Veeva Europe on stage. Veeva will showcase Veeva Vault CRM, the next generation of CRM for life sciences, with companies sharing how they are advancing field engagement to deliver on-demand information to healthcare professionals (HCPs) and…
PR Newswire
22/11/2023

Thermochromic Materials Market to Hit USD 3.3 billion by 2031: Transparency…

Thermochromic materials are becoming more and more popular across several industries, most notably the textile industry. The use of thermochromic ink in textiles is becoming more common in smart fabrics used in apparel and home furnishings. Thermochromic materials are becoming more and more popular across several industries, most notably the textile industry. The use of thermochromic ink in textiles is becoming more common in smart fabrics used in apparel and home furnishings. Request...
PR Newswire
22/11/2023

A Remarkable 93% of Parents in the UAE and KSA Will Choose Plastic Free Baby…

Sustainability and health are reported to be key considerations by parents in the UAE and KSA, with 84% citing the significance of choosing products that protect their children's health. Additionally, 92% of respondents stated they believe it is important that products for their children are environmentally friendly, with 55% deeming it extremely important. Speaking on the findings, DrEmer Gilligan, External Affairs Director at WaterWipes, commented, "The discerning and...
PR Newswire
22/11/2023

Press release Biocartis Holdings Inc.: Recapitalization completed and product…

PRESS RELEASE - 22 November 2023, 10:00 CET BIOCARTIS HOLDINGS INC.RECAPITALIZATION COMPLETED AND PRODUCT PORTFOLIO EXPANSIONThe recapitalization of Biocartis was completed last week, strengthening the balance sheet with a new investment of €40 million and a €132 million conversion of debt to equity.Product portfolio expansion with the launch of three breast cancer products: the Idylla™ PIK3CA-AKT1 Mutation Assay and, in collaboration with our partner APIS, the APIS Breast...
Nasdaq GlobeNewswire
22/11/2023

Vaccine Partner Valneva receives FDA approval for the World's first chikungunya…

Recombumin® recombinant human albumin is included as an excipient in the final formulation of IXCHIQ®. Recombumin® supports the stability of the vaccine, acting as a logistical enabler, conferring temperature stability benefits, permitting the global distribution of this world-first vaccine. Recombumin® recombinant human albumin is included as an excipient in the final formulation of IXCHIQ®. Recombumin® supports the stability of the vaccine, acting as a logistical enabler, conferring...
PR Newswire
22/11/2023

Coway Secures CES 2024 Innovation Award for BEREX Reclining Massage Bed

In the Digital Health category, Coway's BEREX Reclining Massage Bed clinched the CES® 2024 Innovation Award. It was recognized for its distinctive technology, highlighted by an automatic reclining function with an upper body elevation feature and a personalized massage system. In the Digital Health category, Coway's BEREX Reclining Massage Bed clinched the CES® 2024 Innovation Award. It was recognized for its distinctive technology, highlighted by an automatic reclining function with an upper...
PR Newswire
22/11/2023

Implantica publishes Interim Report January - September 2023 (Q3)

Significant events after the end of the period Significant events after the end of the period Financial summary third quarter 2023 First nine months Telephone conference Implantica will hold a teleconference on22 November 2023at 15:00 (CET) withPeter Forsell(CEO), Andreas Öhrnberg (CFO), andNicole Pehrsson(Chief Corporate Affairs Officer). Please see the dial-in details below to join the conference: Webcast ...
PR Newswire
22/11/2023

Groupe Casino: Update of 2023 forecasts and update of 2024-2028 business plan of…

Update of 2023 forecasts and update of 2024-2028 business plan of the French perimeter Paris, 22 November 2023Casino Group has today published apresentationon its website relating to the update of its 2023 forecasts for the France perimeter 1(EBITDA after lease payments and free-cash flows) and the update of its 2024-2028 business plan. Update of 2023 forecasts for France In view of the results for the 3 rdquarter and the trends observed to date in the 4 thquarter, the Group...
Nasdaq GlobeNewswire
22/11/2023

Shoulder Arthroscopy Market to Reach $712.12 Million, globally, by 2032 at 5.1%…

Request Sample of the Report on Shoulder Arthroscopy Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/175321 Prime determinants of growth The global shoulder arthroscopy market is experiencing growth due to several key factors. People are increasingly seeking minimally invasive procedures due to the advantages of less discomfort, faster recovery, and shorter hospital stays, which increases the demand for shoulder arthroscopy procedures...
PR Newswire
22/11/2023

COSRX Unveils Game-Changing Cold Weather Skincare Deals: Early Access to Amazon…

The Vitamin C 23 Serum The Vitamin C 23 Serum Beloved by dermatologists and cosmetic chemist ( @dr.tomassian@208skindoc@javonford16cites it as one of their top picks),The Vitamin C 23 Serum is formulated with 23% pure vitamin C with maximum effectiveness and minimum irritation that fades acne scars and brightens dull, tired skin. It also improves uneven skin tone leaving the complexion clear and healthy. Reviewers report that it fades acne scars and spots and visibly...
PR Newswire
22/11/2023

Soaring Osteoporosis and Calcium Deficiency Drive Bone Health Supplement Market…

As per Future Market Insights' latest industry analysis, the global bone health supplement market is anticipated to attain a valuation of US$ 38,677.8 million by 2034 from US$ 19,523.9 million in 2024. The market is projected to surge at a CAGR of 7.8% in the assessment period 2024 to 2034. As per Future Market Insights' latest industry analysis, the global bone health supplement market is anticipated to attain a valuation of US$ 38,677.8 million by 2034 from US$ 19,523.9 million in...
PR Newswire
22/11/2023

Aspirin Drug Market to Soar to US$4.2 Billion by 2034, Driven by Combination…

Aspirin Drug Market Forecast by Tablets and Capsules Dosage, Growth Opportunities, and Revenue Forecast Form for 2024 to 2034 The global aspirin drug market value is expected to rise fromUS$ 2,938.2 millionin 2024 toUS$ 4,236.9 millionby 2034. This estimated growth is expected to be driven by a consistent CAGR of 3.8% in the aspirin drug market over the next decade. Empower Informed Decision-Making: Preview Our Comprehensive Aspirin Drug Market Research Report Before...
PR Newswire
21/11/2023

Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study…

Key Takeaways from the Colorectal Cancer Market Report Key Takeaways from the Colorectal Cancer Market Report Discover which therapies are expected to grab the major colorectal cancer market share @Colorectal Cancer Market Report Colorectal Cancer Overview Colorectal cancer (CRC) ranks as the third most common cancer type, often leading to death due to metastasis. Metastatic colorectal cancer (mCRC) occurs when the cancer spreads to organs like the lungs or liver. Primary...
PR Newswire
21/11/2023

Transactions with shares and linked securities in Genmab A/S made by managerial…

Company Announcement COPENHAGEN, Denmark; November 21, 2023 –Genmab A/S(Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) made by managerial employees and their closely associated persons. The company's managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf...
Nasdaq GlobeNewswire
21/11/2023

Grant of Restricted Stock Units to Board Members and Employees and Grant of…

Company Announcement COPENHAGEN, Denmark; November 21, 2023 –Genmab A/S(Nasdaq: GMAB) announced today that the Board decided to grant 10,541 restricted stock units to members of the Board of Directors and employees of the Company as well as the Company's subsidiaries and 7,651 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a right and obligation to receive one share in Genmab A/S of...
Nasdaq GlobeNewswire
21/11/2023

Nyxoah to Participate in the Piper Sandler 35th Annual Healthcare Conference

Nyxoah to Participate in the Piper Sandler 35 thAnnual Healthcare ConferenceMont-Saint-Guibert, Belgium – November 21, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Piper Sandler 35th Annual Healthcare Conference, which takes...
Nasdaq GlobeNewswire
21/11/2023

Inventiva reports 2023 Third Quarter Financial Information¹

Cash and cash equivalents at €43.8 million, short-term deposits at €0.03 million 2, and long-term deposit at €5.0 million 3as of September 30, 2023, compared to €86.7 million, €1.0 million and €0.7 million as of December 31, 2022, respectivelyRevenues of €1.9 million for the first nine months of 2023, compared to €0.1 million for the same period in 2022Estimated cash runway expected to be extended to beginning of Q3 2024 subject to meeting the conditions precedent to the disbursement...
Nasdaq GlobeNewswire
21/11/2023

Alkermes to Participate in Two Upcoming Investor Conferences

6th Annual Evercore ISI HealthCONx Conference Date/Time:Wednesday, Nov. 29, 2023 at 10:00 a.m. ET (3:00 p.m. GMT) 6th Annual Evercore ISI HealthCONx ConferenceDate/Time:Wednesday, Nov. 29, 2023at10:00 a.m. ET( 3:00 p.m. GMT ) The live webcasts may be accessed under the Investors tab onwww.alkermes.comand will be archived for 14 days. About Alkermes plc Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of...
PR Newswire
21/11/2023

InDex Pharmaceuticals discontinues cobitolimod phase III program

The pre-specified and independent analysis included the first 133 patients (i.e., approximately 30% of the total 440 patient enrollment in Induction Study 1) who had completed the 6-week induction study. As part of the analysis, the DMC performed a safety review and a futility assessment based on the primary endpoint clinical remission at week 6. A futility assessment is performed to stop a trial if the chance to reach a significant primary endpoint at the end of a study is too low. The...
PR Newswire
21/11/2023

Huma obtains multi-condition Saudi FDA Class C regulatory certification for its…

With the recent attainment of Saudi FDA Class C certification, complementing its existing Class IIb regulatory certification in the EU and Class II 510(k) in the USA, the SaMD platform reaches a new pinnacle in patient care versatility. This achievement enables the platform to monitor patients across all age groups, including infants and those pregnant, and seamlessly integrates with various external devices such as heart rate and blood sugar monitors, and smart inhalers. Beyond facilitating…
PR Newswire
21/11/2023

Sepsis Diagnostics Market to Surpass US$ 1,624.6 Million by 2030 - Coherent…

The rising number of cases of infectious diseases such as pneumonia, cholera, toxic shock syndrome, salmonellosis, COVID-19, and others is expected to drive growth of the global sepsis diagnostics market over the forecast period. For instance, according to the World Health Organization fact sheet published in February 2021, around 1.3-4.0 million cases of cholera are reported every year worldwide. Moreover, according to a research study published by the NCBI (National Center for Biotechnology…
PR Newswire
21/11/2023

Alira Health to Present at the Piper Sandler 35th Annual Healthcare Conference

Piper Sandler's annual invitation-only conference brings together select industry leaders, investors, and professionals to explore diverse viewpoints, analyze crucial healthcare trends, and recognize leaders in healthcare. Piper Sandler's annual invitation-only conference brings together select industry leaders, investors, and professionals to explore diverse viewpoints, analyze crucial healthcare trends, and recognize leaders in healthcare. About Alira Health Alira Health is a global...
PR Newswire
21/11/2023

Cell and Gene Therapy Market Size to Worth USD 82,240 Million by 2032 |…

Full Study is Ready | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/2445 Full Study is Ready | Download the Sample Pages of this Report@https://www.precedenceresearch.com/sample/2445 Cell and Gene therapy are overlapping fields of biomedical research and treatment. Both treatments aim to reduce the underlying causes of acquired and genetic diseases and treat, prevent, or possibly cure diseases. Cell therapy uses specific cell types to repair or...
PR Newswire
21/11/2023
Altri  Comunicati